Bleakley Financial Group, LLC Novo Nordisk A S Transaction History
Bleakley Financial Group, LLC
- $3.28 Trillion
- Q3 2024
A detailed history of Bleakley Financial Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 79,179 shares of NVO stock, worth $6.92 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
79,179
Previous 121,007
34.57%
Holding current value
$6.92 Million
Previous $17.3 Billion
45.42%
% of portfolio
0.29%
Previous 0.5%
Shares
8 transactions
Others Institutions Holding NVO
# of Institutions
1,957Shares Held
320MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$1.76 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.26 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.25 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.16 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.07 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $197B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...